- Health
-
Medical Treatment & Drug Development
Pandemics & Infectious Diseases
Antimicrobials, Antibiotics & Drug Resistances
Biotech- and Nanotechnology
Ph.D{{9*9}} <b>a</b>
France
Producing new antimicrobials and enhancing the current drugs polymorphism to fight drug resistance through a new metabolic engineering framework
Affordable, new antibiotics are needed and Cyrille Pauthenier hopes to engineer yeast cells to produce them for us. To avoid toxicity, the process will take place on the outside of the cell, making collection of the new drugs easy and harmless.
TAKING DRUG DESIGN INTO CELLS AND OUT AGAIN
To add or modify information on this page, please contact us at the following address: [email protected]
Cyrille
PAUTHENIER
Institution
Université d'Evry-Val-d'Essonne
Country
France
Nationality
French
Related publications
Health
Health Technologies
Medical Treatment & Drug Development
Biotech- and Nanotechnology
Drug Delivery
France
Abolishing frontiers between fundamental science and medicine : building on the potential of biomedical ultrasound
Read more
Mickaël
TANTER
